Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV

International Journal of Epidemiology

Volumn 43, Issue 3, 2014, Pages 887-896

  Kouyos, Roger D ^a   Rauch, Andri ^b   Böni, Jürg ^c   Yerly, Sabine ^d   Shah, Cyril ^c   Aubert, Vincent ^e   Klimkait, Thomas ^f   Kovari, Helen ^a   Calmy, Alexandra ^d   Cavassini, Matthias ^e   Battegay, Manuel ^g   Vernazza, Pietro L ^h   Bernasconi, Enos ⁱ   Ledergerber, Bruno ^a   Günthard, Huldrych F ^a   Aubert, V ^j   Barth, J ^j   Battegay, M ^j   Bernasconi, E ^j   Boni J ^j   Bucher, H C ^j   Burton jeangros, C ^j   Calmy, A ^j   Cavassini, M ^j   Egger, M ^j   Elzi, L ^j   Fehr, J ^j   Fellay, J ^j   Francioli, P ^j   Furrer, H ^j   Fux, C A ^j   Gorgievski, M ^j   Gunthard H ^j   Haerry, D ^j   Hasse, B ^j   Hirsch, H H ^j   Hirschel, B ^j   Hosli I ^j   Kahlert, C ^j   Kaiser, L ^j   Keiser, O ^j   Kind, C ^j   Klimkait, T ^j   Kovari, H ^j   Ledergerber, B ^j   Martinetti, G ^j   Martinez de Tejada, B ^j   Metzner, K ^j   Muller N ^j   Nadal, D ^j   Pantaleo, G ^j   Regenass, S ^j   Rickenbach, M ^j   Rudin, C ^j   Schmid, P ^j   Schultze, D ^j   Schoni Affolter F ^j   Schupbach J ^j   Speck, R ^j   Taffe, P ^j   Tarr, P ^j   Telenti, A ^j   Trkola, A ^j   Vernazza, P ^j   Weber, R ^j   Yerly, S ^j   more..

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h CANTONAL HOSPITAL ST GALLEN   (Switzerland)

ⁱ REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^j Regional Hospital Lugano ^*

more..

Author keywords

Genotypic resistance testing; HIV HCV coinfection; Molecular epidemiology; Sexual transmission of HCV

Indexed keywords

DISEASE TRANSMISSION; DRUG USER; EPIDEMIOLOGY; GENOTYPE; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; MORBIDITY; MORTALITY; PHYLOGENY; PUBLIC HEALTH; SEXUALLY TRANSMITTED DISEASE;

ADULT; ARTICLE; CLINICAL STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENOTYPE; HAZARD RATIO; HEPATITIS C; HETEROSEXUALITY; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; MONOPHYLY; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PHYLOGENY; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SUPERINFECTION; CODON; COHORT ANALYSIS; COINFECTION; GENETICS; HEPACIVIRUS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE HOMOSEXUALITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; SWITZERLAND; TRANSMISSION;

SWITZERLAND;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

CODON; VIRUS RNA;

CODON; COHORT STUDIES; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; SWITZERLAND;

EID: 84902657078     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyt276     Document Type: Article

References (26)

1. World Health Organization. WHO Fact Sheet: Hepatitis C. Geneva: WHO, 2013.
2. Rosen HR. Chronic hepatitis C infection. N Engl J Med 2011;364:2429-38.
3. Freeman A. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34:809-16.
4. Vickerman P, Hickman M. The effect of epidemiological setting on the impact of harm reduction targeting injecting drug users: In: Harm reduction: evidence, impacts and challenges. Lisbon: EuropeanMonitoring Centre forDrugs andDrug Addiction, 2010.
5. Theodore Sy MMJ. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006;3:41.
6. Danta M, Rodger AJ. Transmission of HCV in HIV-positive populations. Curr Opin HIVAIDS 2011;6:451-58.
7. van de Laar TJW, van der Bij AK, Prins M. et al. Increase inHCVincidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 2007;196:230-38.
8. Götz HM, van Doornum G, Niesters HG, Hollander den JG, Thio HB, de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men-results from contact tracing and public health implications. AIDS 2005;19:969-74.
9. Vogel M, Boesecke C, Rockstroh JK. Acute hepatitis C infection in HIV-positive patients. Curr Opin Infect Dis 2011;24:1-6.
10. Wandeler G, Gsponer T, Bregenzer A et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: A rapidly evolving epidemic. Clin Infect Dis 2012;55:1408-16.
11. Hasse B, Ledergerber B, Hirschel B et al. Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2010;51:1314-22.
12. Swiss HIV Cohort Study, Schoeni-Affolter F, Ledergerber B et al. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol 2010;39:1179-89.
13. Paraskevis D, Pybus O, Magiorkinis G et al. Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology 2009;6:49.
14. Kouyos RD, Wyl von V, Yerly S et al. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J Infect Dis 2010;201:1488-97.
15. Worobey M, Gemmel M, Teuwen DE et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008;455:661-64.
16. Leigh Brown AJ, Lycett SJ, Weinert L et al. Transmission network parameters estimated from HIV sequences for a nationwide epidemic. J Infect Dis 2011;204:1463-69.
17. Prosperi MCF, Ciccozzi M, Fanti I et al. A novel methodology for large-scale phylogeny partition. Nat Commun 2011;2:321.
18. Gifford RJ, de Oliveira T, Rambaut A et al. Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1. J Virol 2007;81:13050-56.
19. Hué S, Hassan AS, Nabwera H et al. HIV type 1 in a rural coastal town in Kenya shows multiple introductions with many subtypes and much recombination. AIDS Res Hum Retroviruses 2012;28:220-24.
20. Wyl von V, Kouyos RD, Yerly S et al. The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. J Infect Dis 2011;204:1095-103.
21. Wyl von V, Yerly S, Böni J et al. Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Arch Intern Med 2007;167:1782-90.
22. Price MN, Dehal PS, Arkin AP. FastTree 2-approximately maximum-likelihood trees for large alignments. PLoS One 2010;5:e9490.
23. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 2006;22:2688-90.
24. Liu K, Linder CR, Warnow T. RAxML and FastTree. Comparing two methods for large-scale maximum likelihood phylogeny estimation. PLoS One 2011;6:e27731.
25. Deren S, Beardsley M, Coyle S, Singer M. HIV serostatus and risk behaviors in a multisite sample of drug users. J Psychoactive Drugs 1998;30:239-45.
26. Herring BL, Page-Shafer K, Tobler LH, Delwart EL. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis 2004;190:1396-403.